期刊文献+

Primary graft dysfunction after liver transplantation 被引量:12

Primary graft dysfunction after liver transplantation
下载PDF
导出
摘要 BACKGROUND: Primary graft dysfunction (PGD) causes complications in liver transplantation, which result in poor prognosis. Recipients who develop PGD usually experience a longer intensive care unit and hospital stay and have higher mortality and graft loss rates compared with those without graft dysfunction. However, because of the lack of universally accepted definition, early diagnosis of graft dysfunction is difficult. Additionally, numerous factors affect the allograft function after transplantation, making the prediction of PGD more difficult. The present review was to analyze the literature available on PGD and to propose a definition.DATA SOURCE: A search of PubMed (up to the end of 2012) for English-language articles relevant to PGD was performed to clarify the characteristics, risk factors, and possible treatments or interventions for PGD.RESULTS: There is no pathological diagnostic standard; many documented definitions of PGD are different. Many factors such as donor status, procurement and transplant process and recipient illness may affect the function of graft, and ischemia reperfusion injury is considered the direct cause. Potentia managements which are helpful to improve graft function were investigated. Some of them are promising.CONCLUSIONS: Our analyses suggested that the definition of PGD should include one or more of the following variables: (1)bilirubin ≥10 mg/dL on postoperative day 7; (2) internationa normalized ratio ≥1.6 on postoperative day 7; and (3) alanine aminotransferase or aspartate aminotransferase 】2000 IU/L within 7 postoperative days. Reducing risk factors may decrease the incidence of PGD. A majority of the recipients could recover from PGD; however, when the graft progresses intoprimary non-function, the patients need to be treated with retransplantation. BACKGROUND: Primary graft dysfunction (PGD) causes complications in liver transplantation, which result in poor prognosis. Recipients who develop PGD usually experience a longer intensive care unit and hospital stay and have higher mortality and graft loss rates compared with those without graft dysfunction. However, because of the lack of universally accepted definition, early diagnosis of graft dysfunction is difficult. Additionally, numerous factors affect the allograft function after transplantation, making the prediction of PGD more difficult. The present review was to analyze the literature available on PGD and to propose a definition.DATA SOURCE: A search of PubMed (up to the end of 2012) for English-language articles relevant to PGD was performed to clarify the characteristics, risk factors, and possible treatments or interventions for PGD.RESULTS: There is no pathological diagnostic standard; many documented definitions of PGD are different. Many factors such as donor status, procurement and transplant process and recipient illness may affect the function of graft, and ischemia reperfusion injury is considered the direct cause. Potentia managements which are helpful to improve graft function were investigated. Some of them are promising.CONCLUSIONS: Our analyses suggested that the definition of PGD should include one or more of the following variables: (1)bilirubin ≥10 mg/dL on postoperative day 7; (2) internationa normalized ratio ≥1.6 on postoperative day 7; and (3) alanine aminotransferase or aspartate aminotransferase >2000 IU/L within 7 postoperative days. Reducing risk factors may decrease the incidence of PGD. A majority of the recipients could recover from PGD; however, when the graft progresses intoprimary non-function, the patients need to be treated with retransplantation.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2014年第2期125-137,共13页 国际肝胆胰疾病杂志(英文版)
关键词 graft function primary graft dysfunction initial poor function primary non-function liver transplantation graft function primary graft dysfunction initial poor function primary non-function liver transplantation
  • 相关文献

参考文献52

  • 1郑树国,冯晓彬,何振平,卿德科,冷建军,董家鸿.热缺血供肝胆管耐受冷保存时限的实验研究[J].中华肝脏病杂志,2006,14(4):250-254. 被引量:7
  • 2Ahmed Taki-Eldin,Lin Zhou,Hai-Yang Xie,Kang-Jie Chen,Da Yu,Yong He,Shu-Sen Zheng.Triiodothyronine attenuates hepatic ischemia/reperfusion injury in a partial hepatectomy model through inhibition of proinflammatory cytokines, transcription factors, and adhesion molecules[J]. Journal of Surgical Research . 2012 (2)
  • 3Guo-zheng Pan,Yang Yang,Jian Zhang,Wei Liu,Guo-ying Wang,Ying-cai Zhang,Qing Yang,Feng-xian Zhai,Yan Tai,Jian-rong Liu,Qi Zhang,Gui-hua Chen.Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats[J]. Journal of Surgical Research . 2012 (2)
  • 4G. Novelli,V. Morabito,Q. Lai,G.B. Levi Sandri,F. Melandro,F. Pugliese,S. Novelli,M. Rossi,P.B. Berloco.Glasgow Coma Score and Tumor Necrosis Factor α as Predictive Criteria for Initial Poor Graft Function[J]. Transplantation Proceedings . 2012 (7)
  • 5A. E. Braat,J. J. Blok,H. Putter,R. Adam,A. K. Burroughs,A. O. Rahmel,R. J. Porte,X. Rogiers,J. Ringers.The Eurotransplant Donor Risk Index in Liver Transplantation: ET‐DRI[J]. American Journal of Transplantation . 2012 (10)
  • 6R. Ciria,J. Briceno,S. Rufian,A. Luque,P. Lopez-Cillero.Donation after Cardiac Death: Where, When, and How?[J]. Transplantation Proceedings . 2012 (6)
  • 7à. Escorsell,A. Mas,J. Fernández,J.C. García-Valdecasas.Limitations of Use of the Noninvasive Clearance of Indocyanine Green as a Prognostic Indicator of Graft Function in Liver Transplantation[J]. Transplantation Proceedings . 2012 (6)
  • 8H. Obara,N. Matsuno,S. Enosawa,T. Shigeta,H. Huai-Che,T. Hirano,M. Muto,M. Kasahara,S. Uemoto,H. Mizunuma.Pretransplant Screening and Evaluation of Liver Graft Viability Using Machine Perfusion Preservation in Porcine Transplantation[J]. Transplantation Proceedings . 2012 (4)
  • 9T. Shigeta,N. Matsuno,H. Obara,H. Mizunuma,H. Kanazawa,H. Tanaka,A. Fukuda,S. Sakamoto,M. Kasahara,S. Uemoto,S. Enosawa.Functional Recovery of Donation After Cardiac Death Liver Graft by Continuous Machine Perfusion Preservation in Pigs[J]. Transplantation Proceedings . 2012 (4)
  • 10Z. Aydin,M. J. K. Mallat,A. F. M. Schaapherder,A. J. van Zonneveld,C. van Kooten,T. J. Rabelink,J. W. de Fijter.Randomized Trial of Short‐Course High‐Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients[J]. American Journal of Transplantation . 2012 (7)

二级参考文献38

共引文献19

同被引文献54

引证文献12

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部